McKesson is a centralized distribution partner for the US government's COVID vaccine distribution effort.
The Janssen vaccine received Emergency Use Authorization from the US Food and Drug Administration on Feb. 27 and is the first one-shot COVID-19 vaccine to be authorized for use in the United States.
McKesson was selected by the US government in August 2020 to operate as the centralized distributor for frozen and refrigerated COVID-19 vaccines and ancillary supply kits needed to administer them.
In December 2020, McKesson began distributing the ancillary supply kits for Pfizer BioNTech's COVID-19 vaccine.
Later that month, the company began distributing Moderna's COVID-19 vaccine and ancillary supply kits.
McKesson has established four dedicated distribution centers which will be specifically used to distribute the Johnson and Johnson COVID-19 vaccine and future refrigerated vaccines.
The US government makes all program administration decisions, including where, when and how many vaccine doses McKesson will distribute.
McKesson is a healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information solutions company.
Accord Healthcare introduces Dehydrated Alcohol Injection for cardiovascular indications
CARsgen Therapeutics' satri-cel NDA accepted by Chinese regulator
Sanofi receives FDA orphan drug designation for riliprubart in transplant rejection
Hoth Therapeutics reports positive interim results for HT-001 topical therapy
Breckenridge Pharmaceutical's generic for Ablysinol granted final FDA approval
Hemab Therapeutics presents bleeding disorder clinical and preclinical data at ISTH 2025 Congress
Cumberland Pharmaceuticals reports ifetroban Phase 2 DMD heart disease trial results
Sarclisa recommended for EU approval in newly diagnosed transplant-eligible multiple myeloma